US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 677 | -3,143 | -2,416 | -1,269 | -519 |
| Depreciation Amortization | 1 | 2 | 297 | 1 | 1 |
| Accounts receivable | -39 | -19 | -8 | 1 | 0 |
| Accounts payable and accrued liabilities | 173 | -59 | -76 | -71 | -13 |
| Other Working Capital | 183 | 1,196 | 1,006 | 309 | 67 |
| Other Operating Activity | -1,253 | 110 | -372 | -66 | -83 |
| Operating Cash Flow | $-258 | $-1,913 | $-1,569 | $-1,095 | $-546 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -9 | N/A | N/A | N/A |
| Investing Cash Flow | $N/A | $-9 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 117 | 631 | 475 | 418 | 385 |
| Common Stock Issued | 377 | 1,427 | 1,100 | 850 | 400 |
| Other Financing Activity | -64 | -89 | 0 | 0 | 0 |
| Financing Cash Flow | $431 | $1,969 | $1,575 | $1,268 | $785 |
| Beginning Cash Position | 46 | N/A | N/A | N/A | N/A |
| End Cash Position | 219 | 46 | 7 | 173 | 239 |
| Net Cash Flow | $173 | $46 | $7 | $173 | $239 |
| Free Cash Flow | |||||
| Operating Cash Flow | -258 | -1,913 | -1,569 | -1,095 | -546 |
| Capital Expenditure | N/A | -9 | N/A | N/A | N/A |
| Free Cash Flow | -258 | -1,923 | -1,569 | -1,095 | -546 |